Mechanisms of NSAID-Induced Gastroenteropathy Allan H. PriceMichael Fletcher Section 1: A Review 27 November 2012 Pages: 1 - 11
Is There a Rational Basis for the Different Spectra of Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)? K. Brune Section 2: Symposium on NSAIDs 27 November 2012 Pages: 12 - 15
Nonsteroidal Anti-Inflammatory Drug Therapy and Gastric Side Effects P. DandonaJ. Y. Jeremy Section 2: Symposium on NSAIDs 27 November 2012 Pages: 16 - 24
A Microcomputer-Assisted Study of Nabumetone and Slow Release Diclofenac in Osteoarthritis D. LawsS. SaulB. Fehilly Section 2: Symposium on NSAIDs 27 November 2012 Pages: 29 - 33
An Overview of the Long Term Safety Experience of Nabumetone R. F. Willkens Section 2: Symposium on NSAIDs 27 November 2012 Pages: 34 - 37
German Drug Monitoring Studies with Nabumetone I. StroehmannMartin FedderH. Zeidler Section 2: Symposium on NSAIDs 27 November 2012 Pages: 38 - 42
Profile of a Large-Scale Cohort Study A. P. Fletcher Section 2: Symposium on NSAIDs 27 November 2012 Pages: 43 - 47
Meta-Analysis of Italian Clinical Trials of Nabumetone G. VaianiE. Grossi Section 2: Symposium on NSAIDs 27 November 2012 Pages: 48 - 49
Efficacy and Safety of Nabumetone in Patients with Rheumatic Diseases I. StroehmannK. H. GierschP. Münzel Section 2: Symposium on NSAIDs 27 November 2012 Pages: 50 - 52
Effects of the Prodrug Nabumetone, and its Active Metabolite, 6-MNA, on Human and Rat Gastric Mucosal Prostanoids and Platelet Function J. Y. JeremyD. P. MikhailidisP. Dandona Section 2: Symposium on NSAIDs 27 November 2012 Pages: 53 - 56
Penetration of the Active Metabolite of Nabumetone into Synovial Fluid and Adherent Tissue of Patients Undergoing Knee Joint Surgery R. K. MiehlkeS. SchneiderP. Münzel Section 2: Symposium on NSAIDs 27 November 2012 Pages: 57 - 61
Efficacy and Safety of Nabumetone in 4541 Elderly Patients From a Drug Monitoring Study P. MünzelE. E. Lemmel Section 2: Symposium on NSAIDs 27 November 2012 Pages: 62 - 64
Effect of Nabumetone on Patients with RA Evaluated by Isokinetic Muscle Strength A. N. GamA. NawrockiB. Danneskiold-Samsøe Section 2: Symposium on NSAIDs 27 November 2012 Pages: 65 - 66
Nabumetone M. A. BrettG. BuscherA. R. Thawley Section 2: Symposium on NSAIDs 27 November 2012 Pages: 67 - 70
Analgesic Activity of Nabumetone in Postoperative Pain Piergiacomo MoviliaLuigi RestelliEnzo Grossi Section 2: Symposium on NSAIDs 27 November 2012 Pages: 71 - 74
Efficacy and Safety of Nabumetone in 5421 Patients with Osteoarthritis of the Hip and/or Knee Joints M. FedderI. Stroehmann Section 2: Symposium on NSAIDs 27 November 2012 Pages: 75 - 77
Analgesic Activity of Nabumetone Versus Naproxen in Acute Exacerbation of Osteoarthritis M. CazzolaF. MontroneI. Caruso Short Communication 27 November 2012 Pages: 78 - 79
A 12-Month Postmarketing Surveillance Study of Nabumetone P. N. Jenner Section 2: Symposium on NSAIDs 27 November 2012 Pages: 80 - 86